Cutting Costs, Controlling Leverage To Drive Healthcare M&A
Upcoming deal flow in the healthcare industry will be driven by companies looking to bring down costs and improve margins while grappling with circumstances like patent expirations and regulatory scrutiny....To view the full article, register now.
Already a subscriber? Click here to view full article